ARTICLE + VIDEO INFOMMERCIAL: Namazaric for dementia comes in a convenient, extended-release capsule. It conveniently combines today’s 2 most popular drugs for Alzheimer’s. Learn about easy-to-manage Namazaric.
Dementia’s cholinesterase inhibitors can affect trips to the bathroom, according to researchers in Houston, Texas. Learn more if you take donepezil, rivastigmine or galantamine. (Brand names Adlarity, Aricept, Ebixa, Exelon, Namzaric, Razadyne)
A new analysis of the benefits of these Alzheimer’s treatments scores the days and ways patients succeed in living independently.
The EMA has announced its schedule for reviewing the Alzheimer’s drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S. FDA, which already approved the drug, is moving ahead with a new version that doses Leqembi in a better, more convenient fashion for those taking the drug over the long run.
Learn about 2025’s newly approved or potential Alzheimer’s drugs. These include Leqembi, Kisunla, Remternetug, Semaglutide, Trontinemab and Bepranemab.
Leqembi and Kisunla are the new Alzheimer’s immunotherapies. A loss of brain volume associated with these immunotherapies may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue. A new study sheds light on what’s going on.
Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart?
The European Medicines Agency (EMA) recommended approving Leqembi® (generic lecanemab) for Alzheimer’s. Originally skeptics, learn how the “Clarity AD” trial helped change their mind.
Leqembi is an FDA-Approved Alzheimer’s treatment. Hospital infusions take an hour each. 2025 is looking to see a new 15-second autoinjector version. For some, it should even work at home.
Why are some of the new anti-Alzheimer’s antibodies better than others? With the FDA’s approval of Lecanemab and Donanemab, it’s worth staying on top of this topic’s latest research.
Caring for someone with Alzheimer’s goes way beyond helping them get dressed or remembering their pills. For many caregivers, the real struggles happen in quiet moments when you’re alone with feelings nobody else seems to understand.
Fresh air and exercise, improved appetite, fewer medications and happier family visits typify the world’s first “Dementia Village”. See how an inspired nursing home manager took a dreary hospital and turned it into a respect-filled, compassionate community.
UK Biobank data suggest that people with higher blood omega-3 levels in their 40s–60s had a meaningfully lower risk of being diagnosed with dementia before age 65.
The “glymphatic system” removes brain waste. It may be a powerful new target to treat Alzheimer’s. Learn why scientists believe Alzheimer’s may arise when the system is not doing its cleaning properly.
Plaques are the best-known Alzheimer’s culprit. Cambridge scientists have figured out the 7 steps to forming these plaques. Find out how targeting the formation of these “oligomers” may hold the key to a cure.
UCLA researchers found active people build 5% more gray matter in their brain. See how this prevents Alzheimer’s.
Learn about The Alzheimer’s Society of Canada’s campaign to bust the stigma of dementia.
Discover 6 easy ways you can make a difference.
No spam, only news and updates.
